The future of allergy treatment. Would you invest? Comment below if you’re IN or OUT 👇

17 Jun 2022 · 1 min

Watch on YouTube

1:00

In this brief interview, the founder of Windly explains that the company offers a subscription service delivering personalized allergy immunotherapy—medicine made from the exact allergens a patient reacts to—to train the immune system and eliminate chronic allergy symptoms without reliance on drugs like Claritin or Flonase. The founder highlights the sizable market of roughly 40 million Americans with chronic allergies, outlines the revenue model (monthly subscription for the treatment), and describes the scrappy early customer acquisition strategy of answering allergy questions on Reddit, which yielded the first 20 patients. The pitch ends with a call to viewers to comment if they are "in" or "out" on investing.

What is the name of your business? Windly. In one sentence, what does your business do?
We fix allergies for life. What is the problem that you're solving? If you have chronic allergies, you are suffering. You're taking Claritin, you're taking Flonase, you're taking a drug cocktail that makes you feel groggy and doesn't always work. We fix your allergies in a natural way. How big of a problem is this? There are 40 million Americans who suffer from chronic allergies who need to get relief without drugs. And what is the exact solution? We ship you a personalized medicine that is made of exactly what you are allergic to. And over time, we train your immune system to ignore its allergy triggers, the same way you might train your body to run for a marathon. How do you make money? We charge for the treatment. We're on a subscription. You get your medicine every month.
What is the scrappiest thing that you did to build this business?
We started this company just by posting and answering questions on Reddit. Our first 20 patients just came because my co-founder and I were just answering hundreds of questions on Reddit about allergies.
Now it's your turn. Comment below if you're in or out.